"10.1371_journal.pmed.1000278","plos medicine","2010-05-25T00:00:00Z","Nadeem Sarwar; Thor Aspelund; Gudny Eiriksdottir; Reeta Gobin; Sreenivasa Rao Kondapally Seshasai; Nita G Forouhi; Gunnar Sigurdsson; John Danesh; Vilmundur Gudnason","Department of Public Health and Primary Care, University of Cambridge, Cambridge, United Kingdom; Icelandic Heart Association, Kopavogur, Iceland; University of Iceland, Reykjavik, Iceland; MRC Epidemiology Unit, Cambridge, United Kingdom","ICMJE criteria for authorship read and met: NS TA GE RG SRKS NGF GS JD VG. Agree with the manuscript's results and conclusions: NS TA GE RG SRKS NGF GS JD VG. Designed the experiments/the study: NS JD VG. Analyzed the data: NS TA. Collected data/did experiments for the study: NS GE RG SRKS GS VG. Enrolled patients: GS. Wrote the first draft of the paper: NS JD. Contributed to the writing of the paper: NS NS TA NGF GS JD VG. Responsible for data from the Reykjavik Study, derived variables, endpoints and analysis: TA. Contributed to critical revisions of the text: RG SRKS JD. Critically interpreted the findings and revised versions of the manuscript: NGF.","JD has received research funding from the British Heart Foundation, BUPA Foundation, Denka, diaDexus, European Union, Evelyn Trust, GlaxoSmithKline MRC, Merck, National Heart, Lung, and Blood Institute, National Institute of Neurological Disorders and Stroke, Novartis, Pfizer, Roche, Wellcome Trust and UK Biobank. John Danesh is on the Editorial Board of </emph type=\"italic\">PLoS Medicine</emph>.","2010","05","Nadeem Sarwar","NS",9,TRUE,NA,NA,2,2,TRUE,TRUE,FALSE,0,NA,FALSE
